Close
Novotech
Jabsco PureFlo 21 Single Use

IT & Data Management

FDA Discussion Paper On AI And ML Aiming Drug Development

A discussion paper has been published by the US FDA that aims at complementing and informing future guidance on artificial intelligence (AI) and machine learning (ML) usage in drug development. The purpose of this paper is to initiate an...

AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs

Adherence specialists AARDEX Group are proud to announce its partnership with other industry leaders on DiMe’s new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project. Organizations are taking digital clinical measures and products to scale, meaning digital...

Blockchain Revolutionizes Pharma Operations And Profits

The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as well as marketing drugs and other pharmaceutical products. That said, it faces loads of challenges...

Digital Bioprocessing Is Set To Improve Drug Product Quality

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation. The influencing factors identified...

Greenphire Launches GreenSpace App and Expands Global Payment Functionality

Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, announced the expansion of its trusted participant-centered offerings with a robust series of solution enhancements. To enable sponsors, CROs and sites to deliver a consistent...

World Pharma Today – Enhancing Data Infrastructure in Manufacturing with Process Analytical Technologies (PAT)

Enhancing Data Infrastructure in Manufacturing with Process Analytical Technologies (PAT) Securing product quality during manufacturing is essential for the safety and efficacy of the end bioproduct. Improved understanding of manufacturing processes can enhance transparency and ensure the production of high-quality...

Biopharma Spectrum To Be Driven By Automation In Next Decade

One of the reports concerning automation in the biopharmaceutical sector has gone on to show that the market is estimated to grow at a CAGR of 5.7% during the forecast period of 2023–2033. According to the data, the market’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »